Tag : Beneficial

Pharma / Biotech

Itraconazole increases ibrutinib exposure ten-fold and reduces inter-individual variation – A potentially beneficial drug-drug interaction.

Newsemia
Related Articles Itraconazole increases ibrutinib exposure ten-fold and reduces inter-individual variation – A potentially beneficial drug-drug interaction. Clin Transl Sci. 2019 Oct 30;: Authors: Tapaninen...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy